PLSL_HUMAN - dbPTM
PLSL_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PLSL_HUMAN
UniProt AC P13796
Protein Name Plastin-2
Gene Name LCP1
Organism Homo sapiens (Human).
Sequence Length 627
Subcellular Localization Cytoplasm, cytoskeleton . Cell junction . Cell projection . Cell projection, ruffle membrane
Peripheral membrane protein
Cytoplasmic side . Relocalizes to the immunological synapse between peripheral blood T-lymphocytes and antibody-presenting ce
Protein Description Actin-binding protein. [PubMed: 16636079]
Protein Sequence MARGSVSDEEMMELREAFAKVDTDGNGYISFNELNDLFKAACLPLPGYRVREITENLMATGDLDQDGRISFDEFIKIFHGLKSTDVAKTFRKAINKKEGICAIGGTSEQSSVGTQHSYSEEEKYAFVNWINKALENDPDCRHVIPMNPNTNDLFNAVGDGIVLCKMINLSVPDTIDERTINKKKLTPFTIQENLNLALNSASAIGCHVVNIGAEDLKEGKPYLVLGLLWQVIKIGLFADIELSRNEALIALLREGESLEDLMKLSPEELLLRWANYHLENAGCNKIGNFSTDIKDSKAYYHLLEQVAPKGDEEGVPAVVIDMSGLREKDDIQRAECMLQQAERLGCRQFVTATDVVRGNPKLNLAFIANLFNRYPALHKPENQDIDWGALEGETREERTFRNWMNSLGVNPRVNHLYSDLSDALVIFQLYEKIKVPVDWNRVNKPPYPKLGGNMKKLENCNYAVELGKNQAKFSLVGIGGQDLNEGNRTLTLALIWQLMRRYTLNILEEIGGGQKVNDDIIVNWVNETLREAKKSSSISSFKDPKISTSLPVLDLIDAIQPGSINYDLLKTENLNDDEKLNNAKYAISMARKIGARVYALPEDLVEVNPKMVMTVFACLMGKGMKRV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MARGSVSDE
------CCCCCCCHH
25.25-
5Phosphorylation---MARGSVSDEEMM
---CCCCCCCHHHHH
16.9428176443
7Phosphorylation-MARGSVSDEEMMEL
-CCCCCCCHHHHHHH
40.7923401153
11SulfoxidationGSVSDEEMMELREAF
CCCCHHHHHHHHHHH
2.0821406390
20AcetylationELREAFAKVDTDGNG
HHHHHHHHCCCCCCC
33.90133035
20UbiquitinationELREAFAKVDTDGNG
HHHHHHHHCCCCCCC
33.90-
23PhosphorylationEAFAKVDTDGNGYIS
HHHHHCCCCCCCEEE
49.1228796482
28PhosphorylationVDTDGNGYISFNELN
CCCCCCCEEEHHHHH
9.4427155012
30PhosphorylationTDGNGYISFNELNDL
CCCCCEEEHHHHHHH
17.3428450419
39UbiquitinationNELNDLFKAACLPLP
HHHHHHHHHHHCCCC
42.23-
41AcetylationLNDLFKAACLPLPGY
HHHHHHHHHCCCCCC
8.93-
41UbiquitinationLNDLFKAACLPLPGY
HHHHHHHHHCCCCCC
8.93-
48PhosphorylationACLPLPGYRVREITE
HHCCCCCCCHHHHHH
12.1923917254
54PhosphorylationGYRVREITENLMATG
CCCHHHHHHHHHHCC
17.67-
58SulfoxidationREITENLMATGDLDQ
HHHHHHHHHCCCCCC
4.7721406390
76AcetylationISFDEFIKIFHGLKS
CCHHHHHHHHHCCCC
44.6419608861
76UbiquitinationISFDEFIKIFHGLKS
CCHHHHHHHHHCCCC
44.6421906983
82AcetylationIKIFHGLKSTDVAKT
HHHHHCCCCHHHHHH
56.7723749302
82UbiquitinationIKIFHGLKSTDVAKT
HHHHHCCCCHHHHHH
56.7721890473
83PhosphorylationKIFHGLKSTDVAKTF
HHHHCCCCHHHHHHH
34.5830108239
84PhosphorylationIFHGLKSTDVAKTFR
HHHCCCCHHHHHHHH
32.6730108239
88AcetylationLKSTDVAKTFRKAIN
CCCHHHHHHHHHHHH
48.3119608861
88UbiquitinationLKSTDVAKTFRKAIN
CCCHHHHHHHHHHHH
48.3121906983
89PhosphorylationKSTDVAKTFRKAINK
CCHHHHHHHHHHHHH
20.9528122231
97UbiquitinationFRKAINKKEGICAIG
HHHHHHHCCCEEEEC
57.6021890473
106O-linked_GlycosylationGICAIGGTSEQSSVG
CEEEECCCCCCCCCC
24.7132870666
106PhosphorylationGICAIGGTSEQSSVG
CEEEECCCCCCCCCC
24.7130576142
107PhosphorylationICAIGGTSEQSSVGT
EEEECCCCCCCCCCC
36.5928450419
110PhosphorylationIGGTSEQSSVGTQHS
ECCCCCCCCCCCCCC
23.9628450419
111AcetylationGGTSEQSSVGTQHSY
CCCCCCCCCCCCCCC
25.02-
111UbiquitinationGGTSEQSSVGTQHSY
CCCCCCCCCCCCCCC
25.02-
111O-linked_GlycosylationGGTSEQSSVGTQHSY
CCCCCCCCCCCCCCC
25.0232870666
111PhosphorylationGGTSEQSSVGTQHSY
CCCCCCCCCCCCCCC
25.0228450419
114PhosphorylationSEQSSVGTQHSYSEE
CCCCCCCCCCCCCHH
22.4328450419
117PhosphorylationSSVGTQHSYSEEEKY
CCCCCCCCCCHHHHH
22.1223401153
118PhosphorylationSVGTQHSYSEEEKYA
CCCCCCCCCHHHHHH
20.2728450419
119O-linked_GlycosylationVGTQHSYSEEEKYAF
CCCCCCCCHHHHHHH
41.3632870666
119PhosphorylationVGTQHSYSEEEKYAF
CCCCCCCCHHHHHHH
41.3628450419
123UbiquitinationHSYSEEEKYAFVNWI
CCCCHHHHHHHHHHH
45.20-
124PhosphorylationSYSEEEKYAFVNWIN
CCCHHHHHHHHHHHH
14.4625159151
132UbiquitinationAFVNWINKALENDPD
HHHHHHHHHHHCCCC
45.2621890473
140GlutathionylationALENDPDCRHVIPMN
HHHCCCCCCCCCCCC
3.8422555962
148AcetylationRHVIPMNPNTNDLFN
CCCCCCCCCCHHHHH
42.65-
148UbiquitinationRHVIPMNPNTNDLFN
CCCCCCCCCCHHHHH
42.65-
153UbiquitinationMNPNTNDLFNAVGDG
CCCCCHHHHHHHCCC
3.7521890473
164S-palmitoylationVGDGIVLCKMINLSV
HCCCHHEEEECCCCC
1.6229575903
165UbiquitinationGDGIVLCKMINLSVP
CCCHHEEEECCCCCC
38.3621890473
166SulfoxidationDGIVLCKMINLSVPD
CCHHEEEECCCCCCC
2.1021406390
170PhosphorylationLCKMINLSVPDTIDE
EEEECCCCCCCCCCC
27.4121712546
179UbiquitinationPDTIDERTINKKKLT
CCCCCCCCCCCCCCC
27.18-
200PhosphorylationNLNLALNSASAIGCH
HHHHHHHHCCCCCCE
25.1718452278
202PhosphorylationNLALNSASAIGCHVV
HHHHHHCCCCCCEEE
21.9018452278
243PhosphorylationLFADIELSRNEALIA
HHCCCEECCCHHHHH
21.9220068231
257PhosphorylationALLREGESLEDLMKL
HHHHCCCCHHHHHHC
48.1723401153
262SulfoxidationGESLEDLMKLSPEEL
CCCHHHHHHCCHHHH
6.7628465586
263AcetylationESLEDLMKLSPEELL
CCHHHHHHCCHHHHH
53.7826822725
263UbiquitinationESLEDLMKLSPEELL
CCHHHHHHCCHHHHH
53.78-
265PhosphorylationLEDLMKLSPEELLLR
HHHHHHCCHHHHHHH
25.4221815630
276PhosphorylationLLLRWANYHLENAGC
HHHHHHHHHHHHCCC
10.4727155012
285UbiquitinationLENAGCNKIGNFSTD
HHHCCCCCCCCCCCC
56.9421890473
290PhosphorylationCNKIGNFSTDIKDSK
CCCCCCCCCCCCCCH
29.2123401153
291PhosphorylationNKIGNFSTDIKDSKA
CCCCCCCCCCCCCHH
37.2922617229
294AcetylationGNFSTDIKDSKAYYH
CCCCCCCCCCHHHHH
59.7819608861
294UbiquitinationGNFSTDIKDSKAYYH
CCCCCCCCCCHHHHH
59.7819608861
296PhosphorylationFSTDIKDSKAYYHLL
CCCCCCCCHHHHHHH
17.7421949786
297AcetylationSTDIKDSKAYYHLLE
CCCCCCCHHHHHHHH
51.0119608861
297UbiquitinationSTDIKDSKAYYHLLE
CCCCCCCHHHHHHHH
51.0121906983
299PhosphorylationDIKDSKAYYHLLEQV
CCCCCHHHHHHHHHH
8.6428796482
300PhosphorylationIKDSKAYYHLLEQVA
CCCCHHHHHHHHHHC
7.2828796482
322SulfoxidationVPAVVIDMSGLREKD
CCEEEEECCCCCCHH
2.0521406390
323PhosphorylationPAVVIDMSGLREKDD
CEEEEECCCCCCHHH
30.8130576142
337SulfoxidationDIQRAECMLQQAERL
HHHHHHHHHHHHHHH
2.5921406390
351PhosphorylationLGCRQFVTATDVVRG
HCCCCEEEHHHHHCC
25.7329978859
353PhosphorylationCRQFVTATDVVRGNP
CCCEEEHHHHHCCCC
21.6928464451
361AcetylationDVVRGNPKLNLAFIA
HHHCCCCCCCHHHHH
54.7419608861
361UbiquitinationDVVRGNPKLNLAFIA
HHHCCCCCCCHHHHH
54.7419608861
374PhosphorylationIANLFNRYPALHKPE
HHHHHHHCCCCCCCC
8.2527155012
379AcetylationNRYPALHKPENQDID
HHCCCCCCCCCCCCC
55.6825953088
379UbiquitinationNRYPALHKPENQDID
HHCCCCCCCCCCCCC
55.68-
399PhosphorylationGETREERTFRNWMNS
CCCHHHHHHHHHHHH
30.17-
406PhosphorylationTFRNWMNSLGVNPRV
HHHHHHHHCCCCCCH
15.4723401153
417PhosphorylationNPRVNHLYSDLSDAL
CCCHHHHHCCHHHHH
7.8126356563
418PhosphorylationPRVNHLYSDLSDALV
CCHHHHHCCHHHHHH
38.1326356563
430PhosphorylationALVIFQLYEKIKVPV
HHHHHHHHHHCCCCC
12.3722817900
432UbiquitinationVIFQLYEKIKVPVDW
HHHHHHHHCCCCCCH
33.98-
434AcetylationFQLYEKIKVPVDWNR
HHHHHHCCCCCCHHH
52.1025953088
434MethylationFQLYEKIKVPVDWNR
HHHHHHCCCCCCHHH
52.1030783021
434UbiquitinationFQLYEKIKVPVDWNR
HHHHHHCCCCCCHHH
52.10-
444AcetylationVDWNRVNKPPYPKLG
CCHHHCCCCCCCCCC
44.5026822725
444MethylationVDWNRVNKPPYPKLG
CCHHHCCCCCCCCCC
44.50116252109
444UbiquitinationVDWNRVNKPPYPKLG
CCHHHCCCCCCCCCC
44.50-
449AcetylationVNKPPYPKLGGNMKK
CCCCCCCCCCCCHHH
54.6525953088
449UbiquitinationVNKPPYPKLGGNMKK
CCCCCCCCCCCCHHH
54.65-
455AcetylationPKLGGNMKKLENCNY
CCCCCCHHHHCCCCC
59.2025953088
456AcetylationKLGGNMKKLENCNYA
CCCCCHHHHCCCCCE
50.7125953088
456UbiquitinationKLGGNMKKLENCNYA
CCCCCHHHHCCCCCE
50.71-
468AcetylationNYAVELGKNQAKFSL
CCEEEECCCCEEEEE
59.5225953088
468UbiquitinationNYAVELGKNQAKFSL
CCEEEECCCCEEEEE
59.5219608861
472AcetylationELGKNQAKFSLVGIG
EECCCCEEEEEEEEC
26.2319608861
472UbiquitinationELGKNQAKFSLVGIG
EECCCCEEEEEEEEC
26.2319608861
474PhosphorylationGKNQAKFSLVGIGGQ
CCCCEEEEEEEECCC
22.8023401153
502PhosphorylationIWQLMRRYTLNILEE
HHHHHHHHHHHHHHH
12.7621406692
503PhosphorylationWQLMRRYTLNILEEI
HHHHHHHHHHHHHHH
16.1221406692
535PhosphorylationTLREAKKSSSISSFK
HHHHHHHHCCCHHCC
28.7229978859
536PhosphorylationLREAKKSSSISSFKD
HHHHHHHCCCHHCCC
40.3429978859
537PhosphorylationREAKKSSSISSFKDP
HHHHHHCCCHHCCCC
33.3129978859
539PhosphorylationAKKSSSISSFKDPKI
HHHHCCCHHCCCCCC
31.5020068231
540PhosphorylationKKSSSISSFKDPKIS
HHHCCCHHCCCCCCC
34.3529978859
542AcetylationSSSISSFKDPKISTS
HCCCHHCCCCCCCCC
75.0719608861
542UbiquitinationSSSISSFKDPKISTS
HCCCHHCCCCCCCCC
75.0721906983
545UbiquitinationISSFKDPKISTSLPV
CHHCCCCCCCCCCCH
60.46-
547PhosphorylationSFKDPKISTSLPVLD
HCCCCCCCCCCCHHH
20.3320068231
548O-linked_GlycosylationFKDPKISTSLPVLDL
CCCCCCCCCCCHHHH
37.4432870666
548PhosphorylationFKDPKISTSLPVLDL
CCCCCCCCCCCHHHH
37.4420068231
549O-linked_GlycosylationKDPKISTSLPVLDLI
CCCCCCCCCCHHHHH
24.7232870666
549PhosphorylationKDPKISTSLPVLDLI
CCCCCCCCCCHHHHH
24.7220068231
563PhosphorylationIDAIQPGSINYDLLK
HHHHCCCCCCHHHHC
17.8420068231
566PhosphorylationIQPGSINYDLLKTEN
HCCCCCCHHHHCCCC
13.2920068231
579AcetylationENLNDDEKLNNAKYA
CCCCCHHHHHHHHHH
64.6119608861
579UbiquitinationENLNDDEKLNNAKYA
CCCCCHHHHHHHHHH
64.6119608861
584AcetylationDEKLNNAKYAISMAR
HHHHHHHHHHHHHHH
37.0225953088
584UbiquitinationDEKLNNAKYAISMAR
HHHHHHHHHHHHHHH
37.0221890473
589SulfoxidationNAKYAISMARKIGAR
HHHHHHHHHHHHCCE
3.2321406390
598NitrationRKIGARVYALPEDLV
HHHCCEEEECCHHHH
9.25-
598PhosphorylationRKIGARVYALPEDLV
HHHCCEEEECCHHHH
9.2525147952
610UbiquitinationDLVEVNPKMVMTVFA
HHHCCCHHHHHHHHH
38.63-
614PhosphorylationVNPKMVMTVFACLMG
CCHHHHHHHHHHHHC
10.8922817900

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
5SPhosphorylationKinasePRKACAP17612
GPS
5SPhosphorylationKinasePKCAP17252
PSP
5SPhosphorylationKinasePRKCDQ05655
GPS
5SPhosphorylationKinaseRPS6KA1Q15418
GPS
5SPhosphorylationKinaseRPS6KA3P51812
GPS
5SPhosphorylationKinasePKA-FAMILY-GPS
5SPhosphorylationKinasePKA_GROUP-PhosphoELM
7SPhosphorylationKinasePKA-FAMILY-GPS
7SPhosphorylationKinasePKA_GROUP-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PLSL_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PLSL_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RD23B_HUMANRAD23Bphysical
22939629
CNDP2_HUMANCNDP2physical
26344197
PLSI_HUMANPLS1physical
28514442
PLST_HUMANPLS3physical
28514442
RNF41_HUMANRNF41physical
28514442
TTL_HUMANTTLphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PLSL_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-76; LYS-88; LYS-294;LYS-297; LYS-361; LYS-472; LYS-542 AND LYS-579, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; SER-7; TYR-28 ANDSER-30, AND MASS SPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND MASSSPECTROMETRY.
"Costimulation induced phosphorylation of L-plastin facilitatessurface transport of the T cell activation molecules CD69 and CD25.";
Wabnitz G.H., Koecher T., Lohneis P., Stober C., Konstandin M.H.,Funk B., Sester U., Wilm M., Klemke M., Samstag Y.;
Eur. J. Immunol. 37:649-662(2007).
Cited for: SUBCELLULAR LOCATION, FUNCTION, MUTAGENESIS OF SER-5, PHOSPHORYLATIONAT SER-5, AND MASS SPECTROMETRY.
"Phosphorylation on Ser5 increases the F-actin-binding activity of L-plastin and promotes its targeting to sites of actin assembly incells.";
Janji B., Giganti A., De Corte V., Catillon M., Bruyneel E., Lentz D.,Plastino J., Gettemans J., Friederich E.;
J. Cell Sci. 119:1947-1960(2006).
Cited for: FUNCTION, ACTIN-BINDING, INTERACTION WITH ACTIN FIBERS, SUBCELLULARLOCATION, MUTAGENESIS OF SER-5, AND PHOSPHORYLATION AT SER-5.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-28 AND TYR-276, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-124, AND MASSSPECTROMETRY.

TOP